Patents by Inventor Alexander Mark

Alexander Mark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12290597
    Abstract: An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.
    Type: Grant
    Filed: December 30, 2022
    Date of Patent: May 6, 2025
    Assignee: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephen Wargacki, Vincent J. Buono, Susan Shumard, Christopher James Santee
  • Publication number: 20250108017
    Abstract: Pharmaceutical compositions of epinephrine and its prodrugs are described and the compositions having enhanced active component permeation properties are described as being administered with specific residence times.
    Type: Application
    Filed: July 19, 2024
    Publication date: April 3, 2025
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Publication number: 20250074991
    Abstract: The present disclosure relates generally to methods of treating, preventing, or reducing nausea, vomiting, or a combination thereof, hyperemesis gravidarum (HG), nausea and vomiting of pregnancy (NVP), or sequelae thereof in a human subject in need thereof, the method comprising administering to the human subject a therapeutically effective amount of an antibody that specifically binds to human glial cell line-derived neurotrophic factor family receptor alpha-like (GFRAL).
    Type: Application
    Filed: July 30, 2024
    Publication date: March 6, 2025
    Inventors: Alexander Mark DePaoli, Carroll E. Henschel, Jer-Yuan Hsu, Ursula B. Jeffry
  • Publication number: 20250017315
    Abstract: A sole for an article of footwear includes an outsole that has longitudinal ribs and a midsole that is disposed above the outsole and that defines notches. The longitudinal ribs arc disposed in the notches.
    Type: Application
    Filed: September 27, 2024
    Publication date: January 16, 2025
    Inventors: Michel Reginald LUSSIER, Matteo Edmond PADOVANI, George Alan ROBUSTI, Alexander Mark BRILL, Christopher Nelson PADILLA
  • Publication number: 20240430269
    Abstract: An example method of enforcing granular access policy for embedded artifacts comprises: detecting an association of an embedded artifact with a resource container; associating the embedded artifact with at least a subset of an access control policy associated with the resource container; and responsive to receiving an access request to access the embedded artifact, applying the access control policy associated with the resource container for determining whether the access request is grantable.
    Type: Application
    Filed: July 15, 2024
    Publication date: December 26, 2024
    Inventors: Peter Wilczynski, Arseny Bogomolov, Alexander Mark, Teofana Hadzhiganeva, Kevin Ng, Nathaniel Klein, Sharon Hao
  • Patent number: 12171723
    Abstract: Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.
    Type: Grant
    Filed: October 18, 2023
    Date of Patent: December 24, 2024
    Assignee: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Keith Kendall, Dan Barber, Theresa Wood, Peter Boyd, John Maxwell
  • Publication number: 20240412813
    Abstract: The present invention provides a computer-implemented method for estimating the cancer cell fraction (CCF) of at least one tumour-specific mutation in a subject. Also provided are related methods for monitoring the clonal dynamics of a tumour, monitoring a treatment of the tumour and methods for treating a subject having a cancer, as well as systems for implementing the methods of the invention.
    Type: Application
    Filed: October 7, 2022
    Publication date: December 12, 2024
    Applicant: Cancer Research Technology Limited
    Inventors: Alexander Mark Frankell, Christopher Abbosh, Robert Charles Swanton
  • Patent number: 12102168
    Abstract: A sole for an article of footwear includes an outsole that has longitudinal ribs and a midsole that is disposed above the outsole and that defines notches. The longitudinal ribs are disposed in the notches.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: October 1, 2024
    Assignee: adidas AG
    Inventors: Michel Reginald Lussier, Matteo Edmond Padovani, George Alan Robusti, Alexander Mark Brill, Christopher Nelson Padilla
  • Publication number: 20240311863
    Abstract: The present disclosure relates to systems and methods for tracking content across multiple content outlets. Content items, characterized by first metadata, and content slots, characterized by second metadata, can be received. Third metadata for digital content slots can be generated. Fourth metadata can be received. A recommended content item package can be provided based on a comparison between a combination of the first metadata, the second metadata, and the third metadata and the fourth metadata. The recommended content item package can include a content file and a metadata file. A performance and a measurement of the recommended content item package can be determined by executing the metadata file to track the content file across one or more of the content slots and the potential digital content slots. The performance and the measurement can be provided.
    Type: Application
    Filed: May 28, 2024
    Publication date: September 19, 2024
    Applicant: Oracle International Corporation
    Inventors: Jason Loring Canney, Andrew John Grabowski, Hilary Joy Traut, Alexander Mark Robbe, Richard Martin Berger, Megan Margraff, Mohit Gupta, Debra Eskra, Alistair Sutcliffe
  • Publication number: 20240285230
    Abstract: Sleep conditions such as sleep apnea can be assessed using a multi-night assessments. A respiration signal (e.g., acquired from a sensor strip) can be processed via a computing device. The respiration signal can be segmented and the segments can be classified to identify one or more apnea/hypopnea events. In some examples, some of the segments can be normalized such that each segment input for classification can be of the same size. The identified one or more apnea/hypopnea events can be used to estimate a nightly parameter indicative of a severity of (or presence of) sleep apnea. The nightly parameters from a multi-night period can be used to estimate a multi-night parameter indicative of the severity of (or presence of) sleep apnea. In some examples, quality checks can be performed to filter out some data (e.g., to exclude data from entire nights or exclude a portion of data from individual nights).
    Type: Application
    Filed: March 7, 2024
    Publication date: August 29, 2024
    Inventors: Matt Travis BIANCHI, Alexander Mark CHAN, Fredrik J. SANNHOLM, Lifeng MIAO, Siddharth KHULLAR
  • Patent number: 12063218
    Abstract: An example method of enforcing granular access policy for embedded artifacts comprises: detecting an association of an embedded artifact with a resource container; associating the embedded artifact with at least a subset of an access control policy associated with the resource container; and responsive to receiving an access request to access the embedded artifact, applying the access control policy associated with the resource container for determining whether the access request is grantable.
    Type: Grant
    Filed: August 28, 2023
    Date of Patent: August 13, 2024
    Assignee: Palantir Technologies Inc.
    Inventors: Peter Wilczynski, Arseny Bogomolov, Alexander Mark, Teofana Hadzhiganeva, Kevin Ng, Nathaniel Klein, Sharon Hao
  • Publication number: 20240249313
    Abstract: The present disclosure relates to systems and methods for tracking content across multiple content outlets. Content items, characterized by first metadata, and content slots, characterized by second metadata, can be received. Third metadata for digital content slots can be generated. Fourth metadata can be received. A recommended content item package can be provided based on a comparison between a combination of the first metadata, the second metadata, and the third metadata and the fourth metadata. The recommended content item package can include a content file and a metadata file. A performance and a measurement of the recommended content item package can be determined by executing the metadata file to track the content file across one or more of the content slots and the potential digital content slots. The performance and the measurement can be provided.
    Type: Application
    Filed: January 23, 2023
    Publication date: July 25, 2024
    Applicant: Oracle International Corporation
    Inventors: Jason Loring Canney, Andrew John Grabowski, Hilary Joy Traut, Alexander Mark Robbe, Richard Martin Berger, Megan Margraff, Mohit Gupta, Debra Eskra, Alistair Sutcliffe
  • Patent number: 12023309
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Grant
    Filed: June 8, 2022
    Date of Patent: July 2, 2024
    Assignee: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Patent number: 12026740
    Abstract: The present disclosure relates to systems and methods for tracking content across multiple content outlets. Content items, characterized by first metadata, and content slots, characterized by second metadata, can be received. Third metadata for digital content slots can be generated. Fourth metadata can be received. A recommended content item package can be provided based on a comparison between a combination of the first metadata, the second metadata, and the third metadata and the fourth metadata. The recommended content item package can include a content file and a metadata file. A performance and a measurement of the recommended content item package can be determined by executing the metadata file to track the content file across one or more of the content slots and the potential digital content slots. The performance and the measurement can be provided.
    Type: Grant
    Filed: January 23, 2023
    Date of Patent: July 2, 2024
    Assignee: Oracle International Corporation
    Inventors: Jason Loring Canney, Andrew John Grabowski, Hilary Joy Traut, Alexander Mark Robbe, Richard Martin Berger, Megan Margraff, Mohit Gupta, Debra Eskra, Alistair Sutcliffe
  • Publication number: 20240148673
    Abstract: Pharmaceutical compositions of epinephrine and its prodrugs are described, the prodrugs having a half-life of less than one minute, and the compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Patent number: 11937938
    Abstract: Sleep conditions such as moderate-to-severe sleep apnea can be assessed using a multi-night assessments. A respiration signal (e.g., acquired from a sensor strip) can be processed via a computing device. The respiration signal can be segmented and the segments can be classified to identify one or more apnea/hypopnea events. In some examples, some of the segments can be normalized such that each segment input for classification can be of the same size. The identified one or more apnea/hypopnea events can be used to estimate a nightly parameter indicative of a severity of (or presence of) sleep apnea. The nightly parameters from a multi-night period can be used to estimate a multi-night parameter indicative of the severity of (or presence of) sleep apnea. In some examples, quality checks can be performed to filter out some data (e.g., to exclude data from entire nights or exclude a portion of data from individual nights).
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: March 26, 2024
    Assignee: Apple Inc.
    Inventors: Matt Travis Bianchi, Alexander Mark Chan, Fredrik J. Sannholm, Lifeng Miao, Siddharth Khullar
  • Publication number: 20240061829
    Abstract: The present disclosure relates to systems and methods for enhancing data from disjunctive sources using a weighted interaction graph. First data about first entities can be received from a first data source. Second data about second entities at least partially different than the first entities can be received from a second data source. Relationships between each entity of the first entities and second entities can be determined, and a set of classes can be inferred from the first data and from the second data. A weighted interaction graph can be generated. The weighted interaction graph can indicate a likelihood of each entity interacting with a corresponding class. An extended set of data can be generated using the weighted interaction graph. The extended set of data can be output to facilitate communication with third entities that include the first entities and the second entities.
    Type: Application
    Filed: August 19, 2022
    Publication date: February 22, 2024
    Applicant: Oracle International Corporation
    Inventors: Megan Rose Margraff, Jason Loring Canney, Alexander Mark Robbe, Richard Martin Berger
  • Publication number: 20240050317
    Abstract: Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.
    Type: Application
    Filed: October 18, 2023
    Publication date: February 15, 2024
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Keith Kendall, Dan Barber, Theresa Wood, Peter Boyd, John Maxwell
  • Publication number: 20240016734
    Abstract: Pharmaceutical compositions of epinephrine and its prodrugs are described and the compositions having enhanced active component permeation properties are described as being administered with specific residence times.
    Type: Application
    Filed: June 14, 2023
    Publication date: January 18, 2024
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Publication number: 20230414452
    Abstract: Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.
    Type: Application
    Filed: September 7, 2023
    Publication date: December 28, 2023
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Keith Kendall, Dan Barber, Theresa Wood, Peter Boyd, John Maxwell